Trials / Completed
CompletedNCT04850638
Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to evaluate the effect of SHR4640 tablets on the pharmacokinetics of furosemide tablets in healthy male volunteers, using a single-center, single-arm, open, self-control design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR4640 tablets and furosemide tablets | SHR4640 tablets and furosemide tablets |
Timeline
- Start date
- 2021-06-28
- Primary completion
- 2021-09-05
- Completion
- 2021-09-14
- First posted
- 2021-04-20
- Last updated
- 2022-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04850638. Inclusion in this directory is not an endorsement.